CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CORVUS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$22,875
-36.2%
15,6680.0%0.00%
Q2 2023$35,880
+28.1%
15,668
+39.7%
0.00%
Q4 2021$28,000
-49.1%
11,2170.0%0.00%
Q3 2021$55,000
+27.9%
11,217
-18.9%
0.00%
Q1 2021$43,000
-70.5%
13,830
-61.9%
0.00%
Q1 2019$146,000
+52.1%
36,275
+40.1%
0.00%
Q4 2018$96,000
-57.0%
25,9000.0%0.00%
Q3 2018$223,000
-21.8%
25,9000.0%0.00%
Q2 2018$285,000
+41.1%
25,900
+48.0%
0.00%
Q1 2018$202,000
+11.0%
17,5000.0%0.00%
Q4 2017$182,000
-34.8%
17,5000.0%0.00%
Q3 2017$279,000
+31.6%
17,5000.0%0.00%
Q2 2017$212,00017,5000.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$2,784,2740.93%
CHI Advisors LLC 2,384,402$2,026,7420.54%
Telemetry Investments, L.L.C. 390,000$3320.52%
Orbimed Advisors 6,943,654$5,902,1060.11%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 548,727$466,4180.07%
BVF INC/IL 1,370,947$1,165,3050.05%
JACKSON SQUARE CAPITAL, LLC 63,773$54,2070.03%
Artal Group S.A. 500,000$4250.02%
Hikari Power Ltd 49,959$420.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 159,300$135,4050.00%
View complete list of CORVUS PHARMACEUTICALS INC shareholders